Choice of calcineurin inhibitor and development of new malignancies in liver transplant recipients

被引：0
|
作者：
Blum, Eric B. [1 ]
Post, Anthony B. [1 ]
机构：
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 09期
关键词：
D O I：
10.14309/00000434-200609001-00319
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
319
引用
收藏
页码：S150 / S150
页数：1
相关论文
共 50 条
  • [31] Long term effect of sirolimus salvage for chronic calcineurin inhibitor induced nephrotoxicity in liver transplant recipients
    Nair, S
    Cohen, A
    Loss, G
    Eason, J
    GASTROENTEROLOGY, 2004, 126 (04) : A701 - A701
  • [32] Conversion of calcineurin inhibitors to sirolimus in liver transplant recipients.
    Mies, Sergio
    Beduschi, Thiago
    Silva, Vinicius M. R.
    Mies, Ana Olga N. G. F.
    Della Guardia, Bianca
    Baia, Carlos E. S.
    de Almeida, Marcio D.
    LIVER TRANSPLANTATION, 2007, 13 (06) : S189 - S189
  • [33] Hypomaguesemia and outcomes in renal transplant recipients with calcineurin inhibitor toxicity.
    Holzmacher, R
    Hofmann, RM
    Brazy, P
    Becker, B
    Djamali, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 429A - 429A
  • [34] Hypomagnesemia and outcomes in renal transplant recipients with calcineurin inhibitor toxicity.
    Holzmacher, RD
    Kendziorski, C
    Hofmann, MR
    Peter, B
    Bryan, BN
    Djamali, A
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 222 - 222
  • [35] Everolimus exposure in cardiac transplant recipients is influenced by concomitant calcineurin inhibitor
    Brandhorst, Gunnar
    Tenderich, Gero
    Zittermann, Armin
    Oezpeker, Cenk
    Koerfer, Reiner
    Oellerich, Michael
    Armstrong, Victor William
    THERAPEUTIC DRUG MONITORING, 2008, 30 (01) : 113 - 116
  • [36] Conversion to sirolimus for liver recipients with calcineurin inhibitor toxicity.
    McAlister, VC
    Peltekian, K
    Gao, Z
    Colohan, S
    Bitter-Suermann, H
    MacDonald, AS
    TRANSPLANTATION, 2000, 69 (08) : S315 - S315
  • [37] Free calcineurin inhibitor regimen is effective and safe in heart transplant recipients
    Rabago, Gregorio
    Lage, Ernesto
    Crespo, Marisa
    Manito, Nicolas
    Delgado, Juan
    Gonzalez-Vilchez, Francisco
    Segovia, Javier
    Perez-Villa, Felix
    Camprecios, Marta
    Palomo, Jess
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 349 - 349
  • [38] Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
    Ivulich, Steven
    Paul, Eldho
    Kirkpatrick, Carl
    Dooley, Michael
    Snell, Greg
    TRANSPLANT INTERNATIONAL, 2023, 36
  • [39] Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
    Ide, Kentaro
    Tanaka, Yuka
    Onoe, Takashi
    Banshodani, Masataka
    Tazawa, Hirofumi
    Igarashi, Yuka
    Basnet, Nabin Bahadur
    Doskali, Marlen
    Tashiro, Hirotaka
    Ohdan, Hideki
    JOURNAL OF TRANSPLANTATION, 2011, 2011
  • [40] Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients
    Manzia, T. M.
    Angelico, R.
    Toti, L.
    Grimaldi, C.
    Sforza, D.
    Vella, I.
    Tariciotti, L.
    Lenci, I.
    Breshanaj, G.
    Baiocchi, L.
    Tisone, G.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 175 - 183
12345